Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

12.03
-0.3200-2.59%
Post-market: 12.030.00000.00%19:30 EDT
Volume:348.05K
Turnover:4.20M
Market Cap:421.86M
PE:-100.25
High:12.42
Open:12.35
Low:11.88
Close:12.35
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:1.04
T/O Rate:1.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.94
PE(LYR):-35.29

Loading ...

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 22

Fennec Pharmaceuticals shareholders elect directors at annual meeting

Reuters
·
Jun 15

Fennec grants 10,000 inducement stock options priced at $9 to new hire

Reuters
·
Jun 15

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 15

Fennec Pharmaceuticals highlights new ASCO studies on PEDMARK use to prevent cisplatin-induced hearing loss

Reuters
·
Jun 11

Fennec Pharmaceuticals held annual shareholder meeting, elected directors

Reuters
·
Jun 11

Fennec Announces Results of Annual Meeting

GlobeNewswire
·
Jun 11

Fennec Pharmaceuticals director Rosty Raykov disposes of common shares worth $93,790.14

Reuters
·
Jun 03

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

TIPRANKS
·
May 22

Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 22

Fennec price target raised to $16 from $13 at H.C. Wainwright

TIPRANKS
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Fennec says Phase 1 PEDMARK trial in metastatic germ cell tumors opens for accrual

Reuters
·
May 22

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22

Fennec grants 50,000 stock options to new hires at $9.75 per share

Reuters
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 19

Fennec Pharma publishes corporate presentation on PEDMARK hearing loss prevention in cisplatin patients

Reuters
·
May 19

Wedbush Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 18

Piper Sandler Sticks to Its Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 15